These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37358826)

  • 1. Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease M
    Biolatti M; Blangetti M; Baggieri M; Marchi A; Gioacchini S; Bajetto G; Arnodo D; Bucci P; Fioravanti R; Kojouri M; Bersani M; D'Arrigo G; Siragusa L; Ghinato S; De Andrea M; Gugliesi F; Albano C; Pasquero S; Visentin I; D'Ugo E; Esposito F; Malune P; Tramontano E; Prandi C; Spyrakis F; Magurano F; Dell'Oste V
    ACS Infect Dis; 2023 Jul; 9(7):1310-1318. PubMed ID: 37358826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
    Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
    Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Safe and Broad-Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ-AA Peptide Scaffold.
    Wang L; Ma C; Sacco MD; Xue S; Mahmoud M; Calcul L; Chen Y; Wang J; Cai J
    Chemistry; 2023 Jun; 29(35):e202300476. PubMed ID: 36920943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
    Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
    J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    Li J; Lin C; Zhou X; Zhong F; Zeng P; Yang Y; Zhang Y; Yu B; Fan X; McCormick PJ; Fu R; Fu Y; Jiang H; Zhang J
    J Virol; 2022 Apr; 96(8):e0201321. PubMed ID: 35389231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the inhibition of coronaviral main proteases by ensitrelvir.
    Lin C; Jiang H; Li W; Zeng P; Zhou X; Zhang J; Li J
    Structure; 2023 Sep; 31(9):1016-1024.e3. PubMed ID: 37421945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
    Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
    Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.
    Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L
    Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 14. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
    Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J
    ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors.
    Moon P; Zammit CM; Shao Q; Dovala D; Boike L; Henning NJ; Knapp M; Spradlin JN; Ward CC; Wolleb H; Fuller D; Blake G; Murphy JP; Wang F; Lu Y; Moquin SA; Tandeske L; Hesse MJ; McKenna JM; Tallarico JA; Schirle M; Toste FD; Nomura DK
    Chembiochem; 2023 Jun; 24(11):e202300116. PubMed ID: 37069799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
    Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating theobromine as a potential anti-human coronaviral agent.
    Li J; Wang Y; Rajpoot S; Lavrijsen M; Pan Q; Li P; Baig MS
    Microbiol Immunol; 2023 Sep; 67(9):404-412. PubMed ID: 37415325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination.
    Stefanelli I; Corona A; Cerchia C; Cassese E; Improta S; Costanzi E; Pelliccia S; Morasso S; Esposito F; Paulis A; Scognamiglio S; Di Leva FS; Storici P; Brindisi M; Tramontano E; Cannalire R; Summa V
    Eur J Med Chem; 2023 May; 253():115311. PubMed ID: 37043904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
    Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
    J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.